- $2.37bn
- $2.33bn
- $554.18m
Annual income statement for Dave, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 153 | 205 | 259 | 347 | 554 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 202 | 346 | 301 | 279 | 368 |
| Operating Profit | -48.5 | -141 | -42.2 | 68.1 | 187 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.9 | -129 | -48.4 | 60.4 | 168 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -20 | -129 | -48.5 | 57.9 | 196 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -20 | -129 | -48.5 | 57.9 | 196 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -20 | -129 | -48.5 | 57.9 | 196 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.63 | -10.8 | -4.07 | 1.87 | 13.5 |
| Dividends per Share |